MARKET

SAGE

Sage Therapeutic
SAGE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-1.3164
12.91
1.325
544,968,565.96
Supernus Pharma Q3 revenue rises, partly helped by Sage acquisition
Reuters · 11/04 21:34
Supernus Pharmaceuticals reports third quarter revenue of $192.1 million
Reuters · 11/04 21:01
*News On Sage Therapeutics Inc. (SAGE) Now Under SUPN
Dow Jones · 07/31 21:08
Biogen's Q2 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up
NASDAQ · 07/31 14:48
SAGE Therapeutics Announces Nasdaq Delisting After Merger
TipRanks · 07/31 13:24
Sage Therapeutics Inc. Announces Delisting from Nasdaq Following Merger Completion
Reuters · 07/31 13:14
Supernus completes acquisition of Sage Therapeutics
TipRanks · 07/31 12:51
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV)
TipRanks · 07/31 12:50
More

Webull offers Sage Therapeutic stock information, including NASDAQ: SAGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAGE stock methods without spending real money on the virtual paper trading platform.